Distinct mechanisms of cell in breast cancer and their clinical implication.
Breast cancer is a heterogeneous disease affecting women globally.
APA
Li A, Liu S, et al. (2025). Distinct mechanisms of cell in breast cancer and their clinical implication.. Cell biology and toxicology, 42(1), 12. https://doi.org/10.1007/s10565-025-10104-9
MLA
Li A, et al.. "Distinct mechanisms of cell in breast cancer and their clinical implication.." Cell biology and toxicology, vol. 42, no. 1, 2025, pp. 12.
PMID
41366067
Abstract
Breast cancer is a heterogeneous disease affecting women globally. Despite significant advancements in therapeutic interventions in recent years, breast cancer remains a leading cause of cancer-related morbidity in women. Breast cancer's diverse molecular subtypes and escalating complexities in targeted therapies underscore the imperative need to explore novel therapeutic targets. The obstruction of apoptosis and the suppression of cell death are hallmarks of malignant tumors. Cell death, a pivotal regulatory event during tumorigenesis, includes apoptosis, anoikis, autophagy, necroptosis, ferroptosis, pyroptosis, and cuproptosis. This review systematically dissects the molecular underpinnings of cell death pathways in breast cancer, offering novel mechanistic insights and therapeutic opportunities to inform clinical management strategies.
MeSH Terms
Humans; Breast Neoplasms; Female; Autophagy; Apoptosis; Animals; Ferroptosis; Necroptosis; Cell Death
같은 제1저자의 인용 많은 논문 (5)
- Automated quantification of tumor-infiltrating lymphocytes by machine learning reveals prognostic and immunogenomic features in lung cancer.
- Immune-related LncRNA signatures define tumor microenvironment subtypes and predict immunotherapy response in NSCLC.
- Occult obstructive sleep apnea in survivors of Hodgkin lymphoma following radiation therapy: an atypical and under-recognized phenotype.
- Osimertinib with or without savolitinib as first-line treatment for MET-aberrant, EGFR-mutant NSCLC: randomized phase 2 trial (FLOWERS).
- Multi-omics analysis identifies TLRscore for prognostic prediction and highlights TLR8 in macrophage-mediated antitumor immunity of lung adenocarcinoma.